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Abstract
Background: In this study we assessed the respective ability of Affymetrix and Illumina microarray
methodologies to answer a relevant biological question, namely the change in gene expression
between resting monocytes and macrophages derived from these monocytes. Five RNA samples
for each type of cell were hybridized to the two platforms in parallel. In addition, a reference list
of differentially expressed genes (DEG) was generated from a larger number of hybridizations
(mRNA from 86 individuals) using the RNG/MRC two-color platform.
Results: Our results show an important overlap of the Illumina and Affymetrix DEG lists. In
addition, more than 70% of the genes in these lists were also present in the reference list. Overall
the two platforms had very similar performance in terms of biological significance, evaluated by the
presence in the DEG lists of an excess of genes belonging to Gene Ontology (GO) categories
relevant for the biology of monocytes and macrophages. Our results support the conclusion of the
MicroArray Quality Control (MAQC) project that the criteria used to constitute the DEG lists
strongly influence the degree of concordance among platforms. However the importance of
prioritizing genes by magnitude of effect (fold change) rather than statistical significance (p-value)
to enhance cross-platform reproducibility recommended by the MAQC authors was not
supported by our data.
Conclusion: Functional analysis based on GO enrichment demonstrates that the 2 compared
technologies delivered very similar results and identified most of the relevant GO categories
enriched in the reference list.
Background
Microarray-based gene expression analysis is a major com-
ponent of functional genomics research. Using this
approach, researchers can investigate the level of expres-
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sion of all genes in a tissue or cell type in a single experi-
ment [1]. Several questions and concerns about the
reliability, reproducibility and quality of microarray data
have been raised [2] and despite important recent
advances in the evaluation of the existing technologies,
some questions remain unanswered [3] and the scientist
is often lacking arguments to decide on which approach is
best suited for his purpose.
The recently published MicroArray Quality Control
(MAQC) reports [4-9] provide rich information regarding
intra- and inter-platforms reliability. The primary goal of
the MAQC project was to evaluate the technical variability
of DNA microarray results obtained with a number of dif-
ferent microarray technologies. The MAQC results
showed relatively low technical variability in the intra-site
and inter-site measurements, and high inter-platforms
concordance for the thousands of genes identified as dif-
ferentially expressed between 2 reference RNA samples
explored under 4 titration conditions [10,11]. The project
was focused on technical variability and was not trying to
answer a biological question [12]. The present study was
designed to evaluate the ability of 2 commonly utilized
microarray technologies to answer a relevant biological
question, namely the change in gene expression between
resting monocytes and macrophages derived from these
monocytes. M-CSF induced activation of monocytes for 6
days leads to differential regulation of a large number of
genes, and offers the possibility to compare the microar-
ray platforms across a wide range of differential gene
expressions.
Lists of differentially expressed genes (DEG) between
monocytes and macrophages were established according
to various criteria and compared to a reference list derived
from a large number of experiments using a third technol-
ogy. Reproducibility and between platforms comparabil-
ity was assessed on the whole content of each array and on
a subset of well-matched transcripts common to the three
investigated platforms. The biological relevance of the
DEG lists was assessed by testing their enrichment in Gene
Ontology (GO) [13] classes.
Results
Within and between platform consistency of expression 
data
For each platform, reproducibility of absolute and relative
gene expression intensities between pairs of biological
replicates within each sample type were examined on the
subset of transcripts common to the three platforms. In
monocyte samples, the inter-replicates correlation coeffi-
cients of absolute intensities ranged from 0.96 to 0.98 for
Affymetrix, and from 0.98 to 0.99 for Illumina. In macro-
phages the respective ranges were 0.94 to 0.98 and 0.95 to
0.99. The correlations of relative expression (log ratio of
hybridization signals between monocytes and macro-
phages mRNA) between pairs of replicates ranged from
0.82 to 0.94 for Affymetrix arrays and from 0.83 to 0.93
for Illumina arrays. Typical plots of relative expression
intensities for a pair of samples are shown in Figure 1.
These results suggest that both platforms deliver highly
replicable signals. Additional file 1 shows the correlations
Intra-platform reproducibility of the relative expression intensities Figure 1
Intra-platform reproducibility of the relative expression intensities. Scatter plot comparison of the relative expression values (log 2 ratio of gene expression between 
macrophage and monocyte samples) of two different samples on Affymetrix (a) and Illumina (b) platforms. The blue line on each plot represents a regression line that best fits 
the plotted set of points. Both array types provide high inter-replicates reproducibility of the relative gene expression intensities.
a bBMC Genomics 2008, 9:302 http://www.biomedcentral.com/1471-2164/9/302
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coefficients of absolute and relative expression intensities
between all pairs of replicates.
Comparison of detection calls
For the subset of 19,404 transcripts (14,709 genes) com-
mon to the 2 compared platforms and the reference, the
number of probes detected on each platform for each
sample type is shown in Additional file 2 [see Additional
file 3]. Concordance of detection calls between Affymetrix
and Illumina was > 70%. Fifty eight Affymetrix probe sets
called present in the 10 samples were not detected on the
Illumina array (detection score < 0.80) and 185 Illumina
probes detected with a score = 1 were called "absent" on
the Affymetrix platform [see Additional file 3].
Intra-platform reproducibility of replicate probes
Intra-platform reproducibility was also assessed by exam-
ining the expression levels of probes representing the
same genes. Discordances were observed on the 2 plat-
forms, the signal delivered by multiple probes tagging the
same gene being uncorrelated and/or showing differences
in expression levels in opposite direction. Examples of
such discrepancies are available online [see Additional file
4].
Differential expression analysis performed using all probes 
represented on each platform
The number of probes included in this analysis for each
platform is provided online [see Additional file 5]. For a
P-value corrected for multiple testing, Pc < 0.001, the
analysis of Affymetrix data identified 4125 probe sets, cor-
responding to 2890 distinct genes differentially expressed
between monocytes and macrophages. For the same level
of statistical significance, the analysis of Illumina data
identified 2841 differentially expressed probes, corre-
sponding to 2399 unique genes. The reference list estab-
lished using the RNG/MRC data with a Pc < 0.001
threshold included 8317 genes (the higher number of
genes identified is explained by the larger sample size).
The 'Volcano plots' in Figure 2 provide a simultaneous
representation of log2 fold change and statistical signifi-
cance (log-odds) for the gene expression data obtained on
the 2 compared and the reference platforms. For similar
high log-odds the corresponding fold changes is smaller
for data generated on the Illumina (the volcano plot is
high and narrow) than on the Affymetrix platform (the
volcano plot is high and large).
Analysis based on a subset of well-matched transcripts 
common to the 3 platforms
The differential expression analysis was repeated using the
subset of transcripts that were well matched across plat-
forms (The number of probes included in this analysis is
available online [see Additional file 5]). Table 1 provides
the number of genes identified as differentially expressed
on each platform using three different selection criteria: 1.
a Pc < 0.001, 2. a Pc < 0.05 combined with a fold change
> 2, and 3. the Best-3800 probes identified on each plat-
form (as defined below).
Based on the subset of well-matched transcripts and using
the Pc < 0.001 criterion, the Affymetrix microarray identi-
fied 1877 genes (1908 probe sets) and the Illumina
microarray identified 1993 genes (2010 probe IDs) while
the reference list comprised 5204 genes corresponding to
5677 probes. The estimated FDR was < 1% on the three
platforms [see Additional file 6]. The list of these genes
and their associated statistics is provided as Additional
data [see Additional file 7].
Volcano plots representing the relationship between fold change and statistical significance Figure 2
Volcano plots representing the relationship between fold change and statistical significance. On the x-axis are represented the log 2 fold change between the two 
groups (macrophages and monocytes). The vertical axis represents the log-Odds (B-Statistic) computed in Limma. Each gene is represented by a point and an up- and down-reg-
ulated gene appears symmetric. B statistics represents the log-odds that the gene is differentially expressed between the two groups. A low B-value indicates little evidence of 
differential expression. Highlighted genes represent the top 20 significant genes identified on Affymetrix (a), Illumina (b) and RNG-86 (c) platforms.BMC Genomics 2008, 9:302 http://www.biomedcentral.com/1471-2164/9/302
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Overlap in gene lists
The overlap among gene lists for the criteria used in Table
1 is reported in Figure 3(a). The Affymetrix and Illumina
microarrays identified in common 1269 DEG, represent-
ing respectively ~68% and ~64% of all genes identified on
each platform. Eighty seven percent and 89% of the genes
in the Affymetrix and Illumina DEG lists respectively were
also present in the reference list. When the lists were
defined by a combination of a Pc < 0.05 and a fold change
> 2, the number of genes identified in common by the
three microarray platforms decreased to 532, the number
of genes was still large in the Affymetrix list but was con-
siderably reduced in the Illumina and reference lists. The
analysis carried out using all probes represented on each
platform yielded similar conclusion [Additional file 8].
The subset of "Best-3800" probes was established using
the following procedure. 1. For each platform, the list of
probes whose expression differed between monocytes and
macrophages at a Pc < 0.05 was ranked by decreasing fold
change. 2. For a given size of the list, the lists were com-
Inter-platforms agreement in gene lists Figure 3
Inter-platforms agreement in gene lists. Venn diagrams showing the overlap of genes identified as differentially expressed 
between macrophage and monocyte samples in the 2 compared platforms and the reference. Three different criteria were 
used to select gene lists: (a) Pc < 0.001, (b) Pc < 0.05 combined to fold-change >2 as suggested in the MAQC project and (c) 
"Best-3800" probes on each platform. Only a set of transcripts common to the 3 platforms was used in this comparison. Gene 
lists include both up- or down- regulated genes.
1170
142
2950
618 466
99
RNG-86 
(5204)
Affymetrix (1877)
Illumina (1993)
106
adj. P < 0.001
a
Affymetrix (1914)
532
942
51
120
32 210
230
RNG-86 
(894)
Illumina (845)
b
adj. P < 0.05 and 2 FC
Affymetrix (3738)
2134
536
502
617
429 372
696
RNG-86 
(3552)
Illumina (3761)
c
Best 3800 probes
Table 1: Results of the differential expression analysis
Microarray Platform Pc < 0.001# Pc < 0.05 & FC > 2 ## Best 3800 probes###
Affymetrix 1877 genes
(1908 probe sets)
1914 genes
(1945 probe sets)
3738 genes
0.05 < Pc < 10-11
0.48 < |log 2 FC| < 10.38
Illumina 1993 genes
(2010 probes)
845 genes
(854 probes)
3761 genes
0.05 < Pc < 10-11
0.26 < |log 2 FC| < 6.92
Reference list
(RNG-86)
5204 genes
(5677 probes)
894 genes
(933 probes)
3552 gene
0.05 < Pc < 10-79
0.34 < |log 2 FC| < 6.91
Number of differentially expressed genes between macrophage and monocyte samples using different criteria for selecting lists. The analysis was 
performed on the subset of well-matched transcripts common to the three platforms [see Additional file 5] for the number of probes included in 
this analysis for each platform).
# adjusted P-value (Pc) of the moderated t test.
## adjusted P-value of the moderated t test combined to fold change (FC).
### best overlapping lists of genes among platforms (see results section for details).BMC Genomics 2008, 9:302 http://www.biomedcentral.com/1471-2164/9/302
Page 5 of 13
(page number not for citation purposes)
pared and the number of overlapping genes (present in 2
or 3 lists) was plotted against the pre-specified size of the
list (Fig. 4). As illustrated on the Figure 4 the number of
overlapping genes increased with the size of the list and
reached a plateau when the ~3800 top-ranked probes
were selected in each list. Using the "Best-3800" probes,
2134 distinct genes were co-present on the 3 types of
arrays (Fig. 3c). The correlation of fold changes between
the ranked DEG lists was > 0.89 for the 2830 genes co-
present on the Affymetrix and Illumina lists, > 0.88 for the
2506 genes co-present on the Affymetrix and RNG lists,
and > 0.91 for the 2563 genes co-present on the Illumina
and RNG lists. In addition, as the direction of change of
expression of genes present by chance in the lists should
frequently be discordant, the number of genes exhibiting
discordant change for each pair of list was examined. As
shown in Figure 5, discordant changes (genes present in
the top-left and bottom-right quarters of each plot) were
relatively few, representing 0.4%, 0.96% and 1.1% of the
Affymetrix-Illumina, Affymetrix-reference and Illumina-
reference list pairs, respectively.
Gene Ontology (GO) comparison
Additional Table 4 online [see Additional file 9] shows,
for each platform and using two gene list selection criteria,
all GO categories over-represented (Pc < 0.05) in at least
one of the three lists. Using the lists of "Best-3800"
probes, sixteen GO biological processes were significantly
enriched in at least one list; ten, 7 and 15 of these proc-
esses were enriched in the Affymetrix, Illumina and RNG-
86 lists, respectively. The results of the GO analysis are
summarized in Table 2 for the most relevant GO catego-
ries. For each gene list, the number of genes belonging to
a particular GO category and the corresponding adjusted
P-value are provided. For example, the "Immunity and
defense" biological process category comprises 1,154,
1,124 and 1,123 genes among the 18,373, 16,592 and
17,550 genes represented on the Affymetrix, Illumina,
and RNG arrays, respectively; these genes are highly over-
represented in the "Best-3800" reference list (RNG-86) in
which 326 out of 3,549 genes are mapped to this class
[Table 4a, Additional file 9]. This over-representation is
also observed for the Illumina and Affymetrix DEG lists
which identified respectively 351 and 318 genes known to
play a role in the "Immunity and defense" biological proc-
ess. Using the Pc < 0.001 criterion [Table 4b, Additional
file 9], the smaller number of genes within the DEG lists
derived from the Affymetrix and Illumina platforms was
reflected by a smaller number of genes present within rel-
evant GO categories.
When the comparison of the two platforms was focused
on a common set of genes represented on the 3 array
types, the Illumina list tended to include a larger number
of genes belonging to the relevant GO categories than the
Affymetrix list. This observation was made for both crite-
ria used to define gene lists. Conversely, the results of the
GO analysis based on the whole content of each platform
revealed that the Affymetrix platform identified a larger
number of genes within GO categories over-represented
in the reference list [Table 4c, Additional file 9].
Given the high similarities between the Affymetrix and
Illumina platforms in term of number of genes identified
and P-values it was important to check whether these sim-
ilarities reflected the identification of the same genes by
both platforms. Table 3 reports the number of overlap-
ping genes in the "Best-3800" DEG lists according to GO
categories. The last column in the table shows, for each
GO category, the number of genes present in at least one
of the lists. For example, within the "Immunity and
Defense category", 427 genes were present in at least one
of the lists; among them, 235 (55%) were present in the 3
DEG lists. The good performance of the 2 compared plat-
forms relative to the reference is striking. In term of com-
plementarity of platforms, if the genes identified by only
one platform are excluded to limit the number of false
Effect of gene list selection criteria on the degree of inter- platforms concordance Figure 4
Effect of gene list selection criteria on the degree of 
inter-platforms concordance. Number of overlapping 
genes (y-axis) in the 2 and 3 lists of DEG according to the 
size of the list (x-axis). For each platform, the list was consti-
tuted by selecting DEG (Pc < 0.05), then within this list genes 
were ranked according to decreasing fold change. The 
number of overlapping genes between lists was calculated for 
increasing list size. When the number of probes in the lists 
was approximately 3800, the number of overlapping genes 
reached a plateau. The "best 3800" set of probes was defined 
accordingly.BMC Genomics 2008, 9:302 http://www.biomedcentral.com/1471-2164/9/302
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positives, columns 4 and 5 provide the numbers of genes
not identified by the Illumina and Affymetrix platforms
respectively. These numbers are relatively small suggesting
that in the context of this study, each of the 2 compared
platforms provide rather complete information that is lit-
tle complemented by the other platform.
Discussion
Monocytes and macrophages are important players in the
immediate response to foreign agents and in the develop-
ment of the adaptive immune response [14]. Circulating
monocytes are derived from specific myeloid progenitor
cells and under particular conditions they may enter the
arterial wall and mature into macrophages. Macrophages
are involved in the initial process of atherosclerotic
plaques formation, and they are also involved in the
Correlation of fold changes Figure 5
Correlation of fold changes. For each pair-wise comparison, Pearson's correlation coefficients of fold change were calcu-
lated and the direction of change was examined; Genes present in the top-left and bottom right quarters of each plots show 
changes in opposite direction. These genes are expected to overlap by chance.
a b
cBMC Genomics 2008, 9:302 http://www.biomedcentral.com/1471-2164/9/302
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inflammatory events that trigger the rupture of atheroscle-
rotic plaques and clinical events [15]. Investigating the
biology of human blood monocytes, a relatively easily
accessible cell, and macrophages is therefore of crucial
interest for atherosclerosis research. The domain has been
profoundly transformed by the recent availability of
expression microarrays and we may be at the beginning of
a new era in clinical and epidemiological research in
which this technology will be used to investigate gene
expression in circulating cells to predict occurrence, sever-
ity or evolution of disease as well as responses to treat-
ment. Assessing the reproducibility and biological
relevance of available microarray technologies is therefore
of major importance.
The Illumina and Affymetrix microarray technologies dif-
fer in many aspects. While Affymetrix arrays use a set of
different 25-mer probes synthesized in situ [16] to charac-
terize gene expression, Illumina arrays utilize multiple
copies of a single 50-mer probe attached to micro beads to
quantify targets levels [17]. In addition, Affymetrix probes
are located at pre-specified locations on the array while on
the Illumina array, ~30 beads for each probe are randomly
distributed on the array and decoded using specific tag-
ging sequences. These and other technical differences may
lead to different results; data are therefore needed to com-
paratively assess the technologies. Fortunately, recent
large scale studies have provided a wealth of data gener-
ated by a number of array technologies including those
investigated in the present study. According to the results
of the MAQC project the Affymetrix and Illumina arrays
provide highly reproducible results [Fig. 2 in [4]] that cor-
relate well with single gene expression measurements
obtained by RT-PCR and TaqMan assays [Fig. 4 in [7]].
Former comparisons of the Affymetrix and Illumina tech-
nologies also based on a dilution study design led to the
conclusion that both arrays deliver highly correlated
results, especially for relatively high expression levels [18].
Questions remain however regarding the biological rele-
vance of the gene expression measurements and differen-
tial patterns of expression delivered by both approaches
and their possible complementarity. In this paper we
focused on the relative abilities of Affymetrix and Illu-
mina microarrays to characterize the change in gene
expression that parallels the maturation of human blood
Table 3: Degree of overlap in Gene Ontology categories over-represented in the lists of genes selected with the "Best-3800" probes 
criterion.
GO Categories Present in the 
3 lists
Affy and Illum 
only
Affy and RNG-86 
only
Illum and RNG-
86 only
Affy only Illum only RNG-86 only All
Immunity and defense 235 45 21 32 17 39 38 427
Intracellular signaling cascade 137 35 14 23 31 19 34 293
Lipid, fatty acid and steroid 
metabolism
125 30 21 20 13 21 12 242
Apoptosis 86 18 11 14 15 9 21 174
Carbohydrate metabolism 92 20 11 18 9 17 22 189
Protein metabolism and 
modification
355 106 47 77 76 86 121 868
Signal transduction 393 97 55 47 72 54 70 788
Table 2: Gene Ontology comparison.
GO classes Reference lists Affymetrix lists Illumina lists RNG-86 lists
Affy 18373 Illum 16592 RNG 17550 Best 3800 
(n = 3735)
P < 0.001 
(n = 1876)
Best 3800 
(n = 3756)
Pc < 0.001 
(n = 1990)
Best 3800 
(n = 3549)
Pc < 0.001 
(n = 5198)
Immunity and defense 1154 1124 1123 318 * 
(P < 10-5) §
189 (P < 10-8) 351 (P < 10-7) 205 (P < 10-7)3 2 6  ( P  <  1 0 -8) 383 (P < 0.09)
Intracellular signaling 
cascade
818 779 802 217 (P < 0.05) 118 (P < 0.05) 214 (ns) 118 (ns) 208 (P < 0.05) 272 (ns)
Lipid, fatty acid and steroid 
metabolism
673 647 655 189 (P < 10-3) 107 (P < 10-3) 196 (P < 0.05) 119 (P < 10-3) 178 (P < 0.05) 223 (ns)
Apoptosis 470 457 458 130 (P < 0.05) 77 (P < 0.05) 127 (ns) 75 (ns) 132 (P < 0.05) 163 (ns)
Carbohydrate metabolism 520 502 496 132 (ns) 69 (ns) 147 (P < 0.05) 75 (ns) 143 (P < 10-3) 190 (P < 0.05)
Protein metabolism and 
modification
2426 2316 2340 584 (P < 10-3) 283 (ns) 624 (P < 10-4) 342 (P < 10-3)6 0 0  ( P  <  1 0 -8) 836 (P < 10-6)
Signal transduction 2973 2866 2979 617 (ns) 374 (P < 10-3) 591 (ns) 350 (ns) 565 (ns) 733 (P < 10-6)
GO biological process categories over represented in the lists of differentially expressed genes generated on each platform and according to two different selection criteria 
(the "Best 3800" probes or a Pc < 0.001). The table is ordered by the adjusted P-value of the test of association between RNG-86 list and GO categories. For each platform, 
list of DEG was compared to the list of all genes represented on the array. Genes belonging to several GO classes are included several times, once for each GO class that is 
associated with this gene.
* Number of genes in the Affymetrix list annotated to the GO biological process Immunity and defense.
§Adjusted P-value derived from the binomial statistics testing the significance of the enrichment of the Immunity and defense GO category in Affymetrix list.BMC Genomics 2008, 9:302 http://www.biomedcentral.com/1471-2164/9/302
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monocytes into macrophages. To allow this comparison,
a reference panel of differentially expressed genes was
identified using a large number of samples hybridized to
a third type of microarray (2-color RNG/MRC microarrays
[19]. It is well established that macrophages exhibit an
important heterogeneity which depends in vitro on the
type and duration of the stimulus used to generate them
from monocytes and in vivo on their cellular and molec-
ular micro-environment [20]. In addition, the response of
macrophages to stimuli is dynamic and profound, imply-
ing important temporal changes of gene expression that
parallel functional changes. The variability of expression
of this cellular model may therefore be difficult to control
even in rigorously designed experiments, in which the var-
ious sources of variability from the first stages of blood
processing to the preparation of RNA samples are control-
led. Given these premises it was relatively reassuring to
note the high inter-replicates correlation coefficients of
the absolute and relative intensities delivered by both
platforms which most of the times exceeded 0.90 in this
study. The experimental protocol generated a large
number of differentially expressed genes. Using all probes
present on each platform and the Pc < 0.001 criterion, the
Affymetrix and Illumina lists included 2890 and 2399
genes respectively, while 8317 unique genes were present
in the reference list. In our analysis, the two-color micro-
array experiment is not considered as a "gold-standard"
but as a reference used to compare the two commercial
arrays. The much larger number of hybridizations con-
ducted on the RNG/MRC platform led to theidentification
of a large number of differentially expressed genes, many
of which were enriched in pathways relevant to monocyte
and macrophage biology. Using a similar monocytes/
macrophage model other authors [21] observed that 4130
of 13582 genes were differentially expressed. Such mas-
sive change may not reflect the common situation where
researchers investigate highly specific modifications of
expression levels. But changes affecting a wide range of
differential expression levels are of interest to compare
microarray technologies as subtle modifications of expres-
sion generated by a specific differentiating factor may be
better detected by one type of array while another type of
array may be more suitable to evaluate modifications gen-
erated by another differentiating factor.
Several papers have shown that the methods used to pre-
process and analyze gene expression data can strongly
influence the results [6,22,23]. In the present study, we
found that pre-processing methods (background correc-
tion and normalization) can have a profound influence
on the degree of agreement in gene lists among the plat-
forms. For the data generated on the RNG/MRC platform
we investigated several background correction and
within/between array normalization methods imple-
mented in the Limma and marray packages. We found
that the use of different normalization and background
adjustment methods can have a profound influence on
the number of genes found to be differentially expressed
on this platform (data not shown). To limit this problem,
we applied equivalent normalization and statistical anal-
ysis methods to generate the DEG lists for the 2 compared
platforms and the reference.
Discrepancies of results between probes representing the
same gene, observed on the Affymetrix and Illumina plat-
forms (See results) can be attributed to several factors,
including cross-hybridization problems, probe binding to
alternatively spliced transcripts and technical noise.
The most important factor influencing the discordance
among microarray platforms is the criterion used to
define the lists of differentially expressed genes [24,25].
To define gene lists we used the Pc-value, fold change and
the DEG list size. The three different criteria are, of course,
not independent but their combination may lead to very
different results. One of the conclusions of the MAQC
project was that previously reported lack of agreement
among lists of genes generated on different platforms was
due to the use of a statistical significance threshold to
define DEG lists. MAQC's authors [4,6,10] and others
[26] recommended selecting gene lists with a non-strin-
gent P-value cutoff combined to fold-change. Our results
(Table 1, 2nd column) show that when a non stringent Pc-
value (< 0.05) combined to a fold change >2 are used, the
number of differentially expressed genes is considerably
larger for the Affymetrix than for the Illumina platform.
The reason for this discrepancy is evident when examining
the Volcano plots (Fig. 2) which show that for similar sta-
tistical significance, the fold-change is much less impor-
tant for the Illumina than for the Affymetrix data. A fixed
fold change is therefore inappropriate for comparing
these 2 platforms. On the other hand, a relatively more
stringent Pc < 0.001 criterion, irrespective of fold change,
provided more consistent results between the 2 platforms
(Fig. 3). Using this criterion, ~90% of the 1993 genes in
the Illumina list and ~87% of the 1877 in the Affymetrix
list were also present in the reference list. We then used a
selection criterion combining a non stringent statistical
significance threshold (Pc < 0.05) and a "relative" fold
change. In order to take into account the inter-platforms
differences in the magnitude of change, the DEG list was
defined not by a fold change threshold but according to
the size of the list (the same for each platform). As shown
in Figure 4, using this criterion, the overlap among the
lists of the different platforms increases with the size of
the list but reaches a plateau on the Affymetrix and Illu-
mina lists when the size of the lists reaches approximately
3800. The list of "best 3800" was therefore considered as
the most parsimonious list maximizing the overlap
among platforms. As expected, the "best 3800" list corre-BMC Genomics 2008, 9:302 http://www.biomedcentral.com/1471-2164/9/302
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sponded to different fold change thresholds according to
the platforms: 1.40 for Affymetrix, 1.21 for Illumina and
1.27 for the reference.
A major aspect of microarray data analysis is the focus on
classes of functionally related genes rather than on single
genes [27]. This approach has not only increased the rele-
vance of experiments conducted on a small number of
biological replicates but most importantly it offers new
perspectives that are only beginning to be explored in the
area of systems biology. Data analysis approaches investi-
gating classes of related genes necessitate 2 steps: the selec-
tion of gene lists and the test of an over/under
representation of genes belonging to these lists in a priori
defined sets of genes representing functional classes.
Because the main interest is in statistical testing at the level
of the functional classes, it may be appropriate to use a
non-stringent selection criterion to constitute gene lists.
The approach used in this report to characterize gene
enrichment based on GO classes is one among several
possible approaches that rely on various ontology or path-
way databases and utilize different statistical methods to
define gene lists and enrichment [28].
Using the Pc < 0.001 criterion, a smaller number of DEG
were identified within each GO category than when using
the "Best-3800" gene list. This reduced number of identi-
fied genes was not always associated with a proportional
decrease of the corresponding P-values for GO enrich-
ment. This may reflect both a greater specificity of the gene
lists established using the Pc < 0.001 criterion compared
to the "Best-3800" genes criterion and a weaker influence
of the adjustment for multiple testing.
The most relevant GO categories identified by the refer-
ence list (RNG-86) were also significantly over-repre-
sented in the lists identified by the Affymetrix and
Illumina platforms. They included several expected cate-
gories, such as "Immunity and defense", "Apoptosis",
"Intracellular signalling cascade" as well as categories
characterizing general cellular metabolic activities, which
are considered as prominent features of macrophages dif-
ferentiation [29], such as "Protein metabolism", "Carbo-
hydrate metabolism" and "lipid, fatty acid and steroid
metabolism". The complete lists of GO categories over-
represented in the lists of genes differentially expressed
between monocytes and macrophages are reported in
additional Table 4 online [see Additional file 9].
Overall, the Illumina platform performed slightly better
than the Affymetrix one when the platforms were com-
pared using the genes present on both types of array;
whereas the reverse was true when the comparison was
based on the whole set of gene present on each platform.
This is certainly explained by the larger number of genes
represented on the Affymetrix than the Illumina array
(20,252 and 16,756 respectively, see methods). Despite
these differences, the results of the GO analyses were
remarkably similar between platforms in term of identi-
fied GO categories, number of genes present within iden-
tified GO categories and statistical significance.
Conclusion
In conclusion, this work compared the ability of two com-
monly used microarray platforms to characterize the dif-
ferential gene expression profiles of human blood
monocytes and macrophages. A third microarray technol-
ogy applied to a larger number of experiments was used as
reference. The results show that the criterion used to select
the gene lists may considerably affect the results. A selec-
tion procedure coupling a non stringent P-value and "rel-
ative" fold-change identified a list of approximately 3800
probes that optimized the overlap among DEG lists iden-
tified on each platform. A functional analysis based on
GO enrichment demonstrated that the 2 compared tech-
nologies delivered very similar results and despite the
small number of samples, they identified most of the rel-
evant GO categories enriched in the reference list.
Methods
RNA samples
86 samples were obtained from patients with symptoms
of acute coronary syndrome who had undergone coronary
angiography at the department of cardiology of the Pitié-
Salpêtrière Hospital, Paris and who had one stenosis >
50% diagnosed in at least one major coronary artery. This
study was approved by the ethic committee of Pitié-
Salpêtrière Hospital and informed consent was obtained
from all participants.
Experimental design
The objective was to compare 2 commercial microarrays,
Illumina Bead Chip Human-6 V1 [17] and Affymetrix
HGU133plus 2.0 [16] between each other and to a refer-
ence list of DEG established using the academic Réseau
National des Génopoles/Medical Research Council
(RNG/MRC) two-color chip [19]. Monocyte and mono-
cyte-derived macrophage RNA samples from 5 individuals
were hybridized to the 2 types of microarrays. To consti-
tute the reference DEG list, 86 monocyte and 86 macro-
phage samples (38 pools of 2 samples and 10 individual
samples for each type of RNA) were hybridized to RNG/
MRC microarrays (RNG-86).
mRNA preparation, amplification and hybridization on 
microrrays
See additional material online [see Additional file 10] for
a detailed description of the protocols. In short, blood was
drawn under standardized conditions in EDTA tubes: 40BMC Genomics 2008, 9:302 http://www.biomedcentral.com/1471-2164/9/302
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ml samples were collected immediately after coronary
angiography and stored at 4°C. Monocytes isolation was
performed within 2 hours after blood drawing. After den-
sity gradient centrifugation and washing, PMBC were
mixed with CD14 coated beads (MACS, Miltenyi Biotec).
To induce phagocytic differentiation, a fraction of the
monocytes was incubated for 6 days with macrophage
colony stimulating factor (M-CSF, SIGMA). RNA extrac-
tion from monocytes and macrophages was done using
RNAeasy minikit (Qiagen). All RNA preparations were
checked with an Agilent Bioanalyser (RNA 6000 nano-kit)
and only RNA with RNA integrity number (RIN) > 8 were
accepted for RNA amplification. Amplification of RNA,
hybridization, image processing, and raw data extraction
were performed using protocols suitable for each plat-
form.
Background adjustment, normalization and probes 
filtering
For all platforms, low-level analysis (background adjust-
ment, filtering, quality assessment, and normalization)
was performed in the statistical environment R [30]. For
Illumina data, quality control and pre-processing were
performed using the Bioconductor packages BeadArray
and BeadExplorer [31]. Bead-averaged data was normal-
ized using a quantile normalization method [32]. For
Affymetrix data, probe level data was summarized using
the 'Affy' package; only perfect match (PM) probe intensi-
ties were background corrected (RMA method). After
background adjustment, PM intensities were summarized
(Median polish method) into one expression value for
each probe set. The 10 arrays were normalized together
using the quantile method. Data generated on the RNG/
MRC platform were processed using the Bioconductor
packages marray [33] and Limma [34]. Within array print-
tip loess normalization on the background-corrected red
and green intensities (normexp method) was performed
for each spot followed by between array quantile normal-
ization. The number of probes filtered out and included in
the statistical analyses for each platform is available
online [see Additional file 5]; in particular the number of
probes included in the analysis based on a common list of
transcripts after filtering on detection calls was 8310,
8319 and 9777 in the Illumina, Affymetrix and RNG/
MRC lists, respectively (see Additional file 10 for a
description of the filtering procedure).
Gene lists annotation
Gene lists were annotated using the Bioconductor chip
annotation packages (hgu133plus2, IlluminaHumanv1,
and hs25kresogen for Affymetrix, Illumina, and RNG/
MRC, respectively). Entrez gene IDs were used to compare
gene lists generated on the three platforms. In addition,
annotation data provided by chip manufacturers were
used. The NetAffx Analysis Center [35] was used to map
probe sets and annotation information. For the RNG/
MRC array, further annotation information was retrieved
from the Mediante database [36]. According to the Bio-
conductor annotation packages, Affymetrix, Illumina and
RNG/MRC arrays are informative on 20252, 16756,
18339 Entrez IDs, respectively.
Cross-platform probe matching and common list 
construction
Probe matching information from the MAQC project [37]
was used to map probe sequences between Illumina and
Affymetrix. In addition a mapping file comparing probe
content of the Illumina Human-6 v1 array with that of the
Affymetrix HGU133plus2.0 was provided by Illumina
[38]. Probe mapping between the Affymetrix and the
RNG/MRC arrays was available from the Mediante data-
base [36] and allowed the mapping of RNG/MRC ids to
the RefSeq mRNA human database [39] and to the probes
IDs from the two other microarray platforms. This infor-
mation was used to establish a common set of well-
matched transcripts present on the three platforms.
Probes called absent in all samples on the Affymetrix plat-
form and probes with detection score < 0.80 in all samples
on the Illumina platform were removed. When a gene was
represented on a given platform by more than one probe,
all probes were included in the list of common set of tran-
scripts. The resulting list of 19,404 human transcripts
(14,709 genes) was used in the inter-platforms compari-
son based on a common set of transcripts.
Differential expression analysis
For all platforms, differential expression analysis was per-
formed in the same way using the Linear Model for Micro-
array Data (Limma) [40]. Limma provides functions for
fitting a linear model to the expression data for each gene
and performing moderated t-tests which is an empirical
Bayes modification of the t-test to improve variance esti-
mation for small sample sizes. Results from Limma
included log fold change, moderated t-test (t-like statis-
tics), P-value and log odds. Benjamini and Hochberg cor-
rection method was used to account for multiple testing
[41]. The false discovery rate (FDR) was estimated by cal-
culating q-values as described in [42] based on the P val-
ues derived from the moderated t-test statistics. This
estimation was performed using the Bioconductor LBE
(Location Based Estimation) package [43]. For each plat-
form, lists of DEG selected using different statistical signif-
icance and fold change thresholds were generated and
annotated. At similar significance thresholds, the lists
were compared across platforms and to the reference list.
Gene Ontology analysis
To identify Gene Ontology (GO) classes significantly
enriched in the gene lists generated for each platform, a
functional analysis was performed using the Panther Pro-BMC Genomics 2008, 9:302 http://www.biomedcentral.com/1471-2164/9/302
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tein Classification system [44]. For each platform, list of
DEG were annotated with Entrez IDs, uploaded to the
Panther system, mapped onto GO Biological process
classes that were significantly represented, and statistically
compared to the list of all genes represented on the array.
The binomial test [45] was used to look for under- and
over-represented GO categories and a modified Bonfer-
roni correction for multiple comparisons was applied.
Benferroni method was modified to account for the
dependency between GO terms since all genes annotated
to a given GO node are also annotated to all its parents.
Abbreviations
DEG: Differentially Expressed Genes; RNG/MRC: Réseau
National des Génopoles/Medical Research Council; GO:
Gene Ontology; FDR: False Discovery Rate; Limma: Linear
Model for Microarray data; MAQC: MicroArray Quality
Control; M-CSF: Macrophage colony-stimulating factor;
Pc: P-value corrected.
Availability
Raw and processed data from the three microarray plat-
forms have been deposited in the National Center for Bio-
technology Information Gene Expression Omnibus
(GEO, http://www.ncbi.nlm.nih.gov/geo/) public reposi-
tory, and they are accessible through GEO Series accession
number GSE10213 (Illumina data), GSE11430 (Affyme-
trix data) and GSE10220 (RNG/MRC data).
All R scripts used in this analysis are available upon
requests.
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null hypotheses (∏0) was estimated to be 0.273, 0.259 and 0.355 on the 
Affymetrix, Illumina and RNG-86, respectively.
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Additional file 7
List of genes identified as differentially expressed between monocytes 
and macrophages. Genes identified as differentially expressed between 
monocyte and macrophage samples on the three platforms (adjusted P-
value < 0.001).
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Degree of overlap in lists of differentially expressed among the three 
platforms. Venn diagrams of the number of genes identified as differen-
tially expressed between monocyte and macrophage samples. Analysis was 
performed on all probes represented on each platform Affymetrix: 54,613 
probe sets, Illumina: 47,296 probe IDs, RNG/MRC: 25,951 (only control 
probes and bad spots were filtered out). Results are shown for adjusted P-
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